We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Microbubble Technology Could Help Surgeons Target Cancer Better Using Ultrasound

By MedImaging International staff writers
Posted on 08 Mar 2023
Print article
Image: Microbubbles could help cancer patients avoid life-changing surgeries (Photo courtesy of Pexels)
Image: Microbubbles could help cancer patients avoid life-changing surgeries (Photo courtesy of Pexels)

The current method of treating bowel cancer requires surgeons to remove a significant amount of tissue surrounding a tumor in order to eliminate the cancer and prevent it from spreading. Unfortunately, it is only after the tissue is removed that it can be analyzed and confirmed as cancerous. This approach can result in patients needing a stoma and colostomy bag, as the surgery can be quite extensive. Sometimes, this situation may lead to a permanent need for a stoma depending on the severity of the surgery. Now, a new study has found that microbubble technology holds great potential in assisting surgeons to target cancer more precisely. This new technology could greatly minimize the need for invasive surgeries, significantly enhancing the quality of life for bowel cancer patients.

In the study, researchers at The University of Strathclyde (Glasgow, UK) found that by injecting patients with safe microscopic gas bubbles, ultrasound technology could be utilized by surgeons to locate which areas of tissue the cancer has spread to. The acquired data could help minimize the removal of healthy tissue, thus reducing the complexity of surgery and the risks associated with it for the patients. This innovative approach could revolutionize the treatment of bowel cancer in the near future.

The study dealt with the examination of lymph nodes in bowel cancer patients, which represent a crucial aspect in determining any indication of cancer spread as they form part of the immune system. Generally, lymph nodes can be challenging to image; however, through the application of microbubble technology, the researchers were able to differentiate lymph nodes that were cancerous from those that remained healthy. Microbubbles of an inert, safe gas stabilized with a shell of lipid - a layer of fat similar to that existing in the protective outer membrane of human cells – could be injected into the bloodstream of patients.

Ultrasound technology utilizes high-frequency sound waves to generate images of the inside of the body. Upon injection, the microbubbles diffuse through the bloodstream, covering the targeted area for scanning. Upon encountering an ultrasound wave, the microbubbles expand on account of the local pressure change generated by the wave. This results in the expanding microbubbles reflecting additional ultrasound energy back to the scanner, thereby creating brighter ultrasound images that make it easier to identify features like lymph nodes and blood vessels in the circulatory system. This method is already being successfully used in the diagnosis of liver and cardiac diseases, and could hopefully be extended to treat bowel cancer patients. Furthermore, the technology could enable more precise scanning during cancer treatment and aid in monitoring the disease's progression.

“Current practice is for a substantial amount of surrounding tissue to be removed alongside bowel cancer tumors. This can lead to patients requiring a stoma which is a life changing procedure requiring an extensive recovery and adaption period,” said Dr. Helen Mulvana, a Chancellor’s Fellow in Strathclyde’s Department of Biomedical Engineering, who led the research team. “Our hope is that using microbubbles could allow doctors to see which tissue is cancerous during surgery and allow them to remove only what is necessary. This could reduce the extent of surgery, reduce the need for a stoma in many patients, and speed up the post-operative recovery time.”

Related Links:
The University of Strathclyde

Gold Member
Solid State Kv/Dose Multi-Sensor
Ultrasound Table
Ergonomic Advantage (EA) Line
Enterprise Imaging & Reporting Solution
Syngo Carbon
X-Ray QA Meter
Piranha CT

Print article


Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.